BioMarin Pharmaceutical

Company Information

As of 6/2/21
Country
U.S.
Headquarters
San Rafael, Calif.
Industry
Pharmaceuticals
CEO
Jean-Jacques Bienaimé
Company Type
Public
Ticker
BMRN
Revenues ($M)
$1,860.5
Profits ($M)
$859.1
Market Value ($M)
$13,730
Employees
3,059
Market value as of March 31, 2021.

Key Financials (Last Fiscal Year)

$ millions
% change
Revenues ($M)
$1,860.5
9.2%
Profits ($M)
$859.1
-
Assets ($M)
$5,848
-
Total Stockholder Equity ($M)
$4,106
-

Profit Ratios

Profit as % of Revenues
46.2%
Profits as % of Assets
14.7%
Profits as % of Stockholder Equity
20.9%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)
453
EPS % Change (from 2019)
-
EPS % Change (5 year annual rate)
-
EPS % Change (10 year annual rate)
10.1%

Total Return

Total Return to Investors (2020)
3.7%
Total Return to Investors (5 year, annualized)
-3.5%
Total Return to Investors (10 year, annualized)
12.5%

Measure Up Diversity & Inclusion Metrics

Measure Up Rank
-
Provides Day Care Services
-
Facilitates Employee Resource Groups
-
Has a Policy on Board Diversity
-
Has a Policy on Diversity and Opportunity
-
Has Targets Toward Diversity and Opportunity
-
% of Employees With Disabilities
-
% of New Employees Who Are Women
-
% of Employees Who Are Women
-
% of Managers Who Are Women
-
Gender Pay Gap %
-
% of Board Members Who Are Minorities
-
% of Employees Who Are Minorities
-
% of Managers Who Are Minorities
-
Minorities Salary Gap %
-
Lists ranking BioMarin Pharmaceutical